Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06454149

Cohort Study for Gastric MALT Lymphoma

The goal of this observational study is to establish clinical data and tissue repository in patients with gastric MALT lymphoma and controls.

Participants will be asked to provide clinical information and various tissues (saliva, gastric mucosa, and feces).

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Gastric MALT Lymphoma

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Korea University Ansan Hospital, Ansan-si, Gyeonggi-do, South Korea

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

[MALT lymphoma group]

  • Newly diagnosed as gastric MALT lymphoma [Control group]
  • Patients who underwent
  • diagnosed upper endoscopy for dyspepsia and had chronic gastritis,
  • therapeutic upper endoscopy for gastric hyperplastic polyps, or
  • screening upper endoscopy without any symptoms.

Exclusion criteria

  • History of gastric or other malignancy
  • Use of antibiotics or probiotics within 4 weeks
  • Uncontrolled chronic illnesses

Treatment and study plan

MALT lymphoma

Other

New diagnosis with gastric MALT lymphoma

Primary outcomes

  1. Remission of gastric MALT lymphoma

    Time frame: Within 3 years from diagnosis

    Remission of gastric MALT lymphoma

Secondary outcomes

  1. Eradication of H. pylori infection

    Time frame: Within 6 month from eradication therapy

    Eradication of H. pylori infection

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Collaborators

  • Kangbuk Samsung Hospital
  • Korea University Ansan Hospital

Registry information

Official study title

Establishment of a Cohort for Investigating the Pathophysiology of Gastric MALT Lymphoma

Acronym: HUG-MALToma

Important dates

Study start
2024
Primary completion
2028
Study completion
2031
First posted
Jun 12, 2024
Registry last updated
Jun 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.